BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 28847562)

  • 1. Cannabis use during pregnancy: Pharmacokinetics and effects on child development.
    Grant KS; Petroff R; Isoherranen N; Stella N; Burbacher TM
    Pharmacol Ther; 2018 Feb; 182():133-151. PubMed ID: 28847562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Verification of a Linked
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined vapor exposure to THC and alcohol in pregnant rats: Maternal outcomes and pharmacokinetic effects.
    Breit KR; Rodriguez CG; Lei A; Thomas JD
    Neurotoxicol Teratol; 2020; 82():106930. PubMed ID: 33086086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development.
    Breit KR; Rodriguez CG; Lei A; Hussain S; Thomas JD
    Alcohol Clin Exp Res; 2022 Aug; 46(8):1408-1422. PubMed ID: 35722858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.
    Richardson KA; Hester AK; McLemore GL
    Neurotoxicol Teratol; 2016; 58():5-14. PubMed ID: 27567698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
    Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
    J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal-fetal transmission of delta-9-tetrahydrocannabinol (THC) and its metabolites following inhalation and injection exposure during pregnancy in rats.
    Baglot SL; VanRyzin JW; Marquardt AE; Aukema RJ; Petrie GN; Hume C; Reinl EL; Bieber JB; McLaughlin RJ; McCarthy MM; Hill MN
    J Neurosci Res; 2022 Mar; 100(3):713-730. PubMed ID: 34882838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational exposure to Δ
    Martínez-Peña AA; Lee K; Petrik JJ; Hardy DB; Holloway AC
    J Dev Orig Health Dis; 2021 Dec; 12(6):865-869. PubMed ID: 33407988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
    Goullé JP; Guerbet M
    Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Delta-9-Tetrahydrocannabinol Exposure Induces Abnormalities of the Developing Heart in Mice.
    Robinson GI; Ye F; Lu X; Laviolette SR; Feng Q
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):121-133. PubMed ID: 36255470
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes.
    Shorey-Kendrick LE; Roberts VHJ; D'Mello RJ; Sullivan EL; Murphy SK; Mccarty OJT; Schust DJ; Hedges JC; Mitchell AJ; Terrobias JJD; Easley CA; Spindel ER; Lo JO
    Clin Epigenetics; 2023 Jul; 15(1):104. PubMed ID: 37415206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review.
    Roncero C; Valriberas-Herrero I; Mezzatesta-Gava M; Villegas JL; Aguilar L; Grau-López L
    Reprod Health; 2020 Feb; 17(1):25. PubMed ID: 32066469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal cannabis exposure and infant outcomes: overview of studies.
    Huizink AC
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():45-52. PubMed ID: 24075896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pregnancy and associated hormones on the pharmacokinetics of Δ
    Authement AK; Isoherranen N
    Expert Opin Drug Metab Toxicol; 2024; 20(1-2):73-93. PubMed ID: 38258511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of in utero cannabis exposure by umbilical cord analysis.
    Kim J; de Castro A; Lendoiro E; Cruz-Landeira A; López-Rivadulla M; Concheiro M
    Drug Test Anal; 2018 Apr; 10(4):636-643. PubMed ID: 28948698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and synaptic reprogramming of the developing brain.
    Bara A; Ferland JN; Rompala G; Szutorisz H; Hurd YL
    Nat Rev Neurosci; 2021 Jul; 22(7):423-438. PubMed ID: 34021274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use during pregnancy and postpartum.
    Badowski S; Smith G
    Can Fam Physician; 2020 Feb; 66(2):98-103. PubMed ID: 32060189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes.
    Smid MC; Metz TD; McMillin GA; Mele L; Casey BM; Reddy UM; Wapner RJ; Thorp JM; Saade GR; Tita ATN; Miller ES; Rouse DJ; Sibai B; Costantine MM; Mercer BM; Caritis SN;
    Obstet Gynecol; 2022 Jan; 139(1):21-30. PubMed ID: 34856574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical toxicology of cannabis.
    Schep LJ; Slaughter RJ; Glue P; Gee P
    N Z Med J; 2020 Oct; 133(1523):96-103. PubMed ID: 33032307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and paternal cannabis use during pregnancy and the risk of psychotic-like experiences in the offspring.
    Bolhuis K; Kushner SA; Yalniz S; Hillegers MHJ; Jaddoe VWV; Tiemeier H; El Marroun H
    Schizophr Res; 2018 Dec; 202():322-327. PubMed ID: 29983267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.